Evidence map›Paper›PMID 39665446›Full record

ArticleStatistics in medicine2025

A Simple Information Criterion for Variable Selection in High-Dimensional Regression.

Matthieu Pluntz, Cyril Dalmasso, Pascale Tubert-Bitter, Ismaïl Ahmed

Abstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthieu PluntzHigh-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Villejuif, France.ORCID 0000-0002-4448-5842
Cyril DalmassoLaboratoire de Mathématiques et Modélisation d'Évry (LaMME), Université d'Evry Val d'Essonne, Évry, France.
Pascale Tubert-BitterHigh-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Villejuif, France.
Ismaïl AhmedHigh-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Villejuif, France.ORCID 0000-0003-0468-6858

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-dimensional regression problems, for example with genomic or drug exposure data, typically involve automated selection of a sparse set of regressors. Penalized regression methods like the LASSO can deliver a family of candidate sparse models. To select one, there are criteria balancing log-likelihood and model size, the most common being AIC and BIC. These two methods do not take into account the implicit multiple testing performed when selecting variables in a high-dimensional regression, which makes them too liberal. We propose the extended AIC (EAIC), a new information criterion for sparse model selection in high-dimensional regressions. It allows for asymptotic FWER control when the candidate regressors are independent. It is based on a simple formula involving model log-likelihood, model size, the total number of candidate regressors, and the FWER target. In a simulation study over a wide range of linear and logistic regression settings, we assessed the variable selection performance of the EAIC and of other information criteria (including some that also use the number of candidate regressors: mBIC, mAIC, and EBIC) in conjunction with the LASSO. Our method controls the FWER in nearly all settings, in contrast to the AIC and BIC, which produce many false positives. We also illustrate it for the automated signal detection of adverse drug reactions on the French pharmacovigilance spontaneous reporting database.

Indexed as

Computer SimulationHumansLikelihood FunctionsLinear ModelsLogistic ModelsModels, StatisticalRegression AnalysisFWER controlhigh‐dimensional regressioninformation criterionLASSOpharmacovigilancevariable selection

Identifiers

PMID39665446
PMCPMC11702156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.